Combination Treatment with Daclatasvir Produces Good Results in Patients with Genotype 4 Hepatitis C
SVR12 rates significantly higher in patients treated with daclatasvir/peginterferon alfa/ribavirin combination.
HCP Live Staff
Advertisement
Articles by HCP Live Staff
Advertisement
Latest Updated Articles
Combination Treatment with Daclatasvir Produces Good Results in Patients with Genotype 4 Hepatitis CPublished: October 15th 2014 | Updated:
Advertisement
Advertisement
